Page 5 - Chromadex Tru Niagen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Chromadex tru niagen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Chromadex Tru Niagen Today - Breaking & Trending Today

ChromaDex (NASDAQ:CDXC) Lifted to Strong-Buy at StockNews.com

StockNews.com upgraded shares of ChromaDex (NASDAQ:CDXC – Free Report) from a buy rating to a strong-buy rating in a report issued on Friday. Other equities research analysts also recently issued research reports about the company. HC Wainwright decreased their target price on ChromaDex from $5.50 to $5.00 and set a buy rating for the company […] ....

United Kingdom , United States , Pricet Rowe Associates Inc , Geode Capital Management , Cambridge Investment Research Advisors Inc , America Corp , Chromadex Corporation , Free Report , Capital Management , Investment Research Advisors , Street Corp , Pricet Rowe Associates , Xidex Corporation , Analytical Reference Standards , Chromadex Daily , Nasdaq Cdxc , Stocknews Com ,

Frank L. Jaksch, Jr. Purchases 7,000 Shares of ChromaDex Co. (NASDAQ:CDXC) Stock

ChromaDex Co. (NASDAQ:CDXC – Get Rating) Director Frank L. Jaksch, Jr. acquired 7,000 shares of the business’s stock in a transaction dated Monday, June 12th. The stock was purchased at an average cost of $1.69 per share, with a total value of $11,830.00. Following the transaction, the director now owns 231,339 shares of the company’s […] ....

Frankl Jaksch Jr , Chromadex Co , Gabelli Funds , Chromadex Corp , Squarepoint Ops , Sigma Securities , Susquehanna International Group , Get Rating , Director Frank , Dex Stock Down , International Group , Street Corp , Nicotinamide Riboside , Chromadex Daily , Nasdaq Cdxc , Insider Trading , Nsider Trades ,

Core Gold (CVE:CGLD) Shares Down 3% | Daily Political

ChromaDex Co. (NASDAQ:CDXC – Get Rating) – Stock analysts at HC Wainwright cut their Q2 2023 earnings per share estimates for ChromaDex in a research report issued to clients and investors on Monday, June 5th. HC Wainwright analyst R. Selvaraju now anticipates that the company will earn ($0.05) per share for the quarter, down from […] ....

Gabelli Funds , Squarepoint Ops , Susquehanna International Group , Chromadex Corp , Chromadex Company Profile , Sigma Securities , Chromadex Co , Get Rating , International Group , Street Corp , Nicotinamide Riboside , Chromadex Daily , Nasdaq Cdxc , Earnings Estimates , Hc Wainwright ,

ChromaDex (NASDAQ:CDXC) Cut to Buy at StockNews.com

StockNews.com lowered shares of ChromaDex (NASDAQ:CDXC – Get Rating) from a strong-buy rating to a buy rating in a research note issued to investors on Thursday. Several other equities analysts also recently commented on the stock. HC Wainwright decreased their price objective on shares of ChromaDex from $5.50 to $5.00 and set a buy rating […] ....

United Kingdom , Chromadex Corp , Vanguard Group Inc , Cambridge Investment Research Advisors Inc , Topco Ltd , Chromadex Company Profile , Renaissance Technologies , Jpmorgan Chase Co , Get Rating , Investment Research Advisors , Nicotinamide Riboside , Chromadex Daily , Nasdaq Cdxc , Stocknews Com ,

ChromaDex (NASDAQ:CDXC) Stock Rating Lowered by StockNews.com

StockNews.com lowered shares of ChromaDex (NASDAQ:CDXC – Get Rating) from a strong-buy rating to a buy rating in a research report sent to investors on Thursday. CDXC has been the subject of several other research reports. LADENBURG THALM/SH SH decreased their price objective on ChromaDex from $7.50 to $6.60 in a report on Thursday, May […] ....

United States , Virtu Financial , America Corp , Chromadex Corp , Gabelli Funds , International Assets Investment Management , Squarepoint Ops , Get Rating , Assets Investment Management , Nicotinamide Riboside , Chromadex Daily , Nasdaq Cdxc , Stocknews Com ,